Onc.AI
Onc.AI is a privately held digital health company on a mission to radically improve oncology decision making. By leveraging a market-leading oncology real-world dataset, Onc.AI develops AI models to fulfill the potential of precision oncology, with products predicting clinical outcomes in metastatic lung cancer to inform pharma clinical development and medical oncologist decision-making.
Industries
Nr. of Employees
small (1-50)
Products
Imaging-based lung clinical management test (investigational)
An imaging AI test that produces patient-specific prognostic risk stratification and standardized imaging biomarker reports to support management of metastatic lung cancer patients.
Serial CT response scoring model (deep-learning) — regulatory-designated
A deep-learning model that scores serial CT studies to assess early therapeutic response; reported to have received FDA Breakthrough Device designation for accelerated regulatory review.
Imaging-based lung clinical management test (investigational)
An imaging AI test that produces patient-specific prognostic risk stratification and standardized imaging biomarker reports to support management of metastatic lung cancer patients.
Serial CT response scoring model (deep-learning) — regulatory-designated
A deep-learning model that scores serial CT studies to assess early therapeutic response; reported to have received FDA Breakthrough Device designation for accelerated regulatory review.
Services
Imaging-based clinical decision-support service for metastatic lung cancer
Secure, automated service that ingests routine CT scans, extracts imaging biomarkers, produces patient-specific prognostic scores and delivers clinician-facing reports to inform treatment decisions.
Pharma clinical analytics and trial enrichment service
Analytics offering for clinical development teams to support patient stratification, arm balancing, early response assessment and go/no-go decision support using imaging-derived biomarkers.
Imaging-based clinical decision-support service for metastatic lung cancer
Secure, automated service that ingests routine CT scans, extracts imaging biomarkers, produces patient-specific prognostic scores and delivers clinician-facing reports to inform treatment decisions.
Pharma clinical analytics and trial enrichment service
Analytics offering for clinical development teams to support patient stratification, arm balancing, early response assessment and go/no-go decision support using imaging-derived biomarkers.
Expertise Areas
- Medical imaging AI
- Radiomics and quantitative imaging
- Clinical decision support for oncology
- Clinical trial analytics and patient stratification
Key Technologies
- Deep learning for image analysis
- Radiomic feature extraction
- CT image volumetric analysis
- Cloud-based de-identification pipelines